Dermatology · PANCE / PANRE

Bullous Pemphigoid

Most common autoimmune subepidermal blistering disease of the elderly; tense bullae on an urticarial base.

Also known as: BP, pemphigoid, subepidermal blistering

Overview

Chronic autoimmune subepidermal blistering disorder driven by IgG autoantibodies against hemidesmosomal antigens BP180 (BPAG2) and BP230 (BPAG1) at the dermoepidermal junction. Characterized by tense bullae on erythematous or urticarial skin, prominent pruritus, and infrequent mucosal involvement.

Epidemiology

Most common autoimmune blistering disease in Western countries. Incidence rises sharply with age; majority of patients >70. Slight female predominance. Increased risk in patients with neurologic disease (Parkinson disease, dementia, stroke, multiple sclerosis) and with use of DPP-4 inhibitors (gliptins) and immune checkpoint inhibitors.

Try two board-style Bullous Pemphigoid questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1DermatologyMedium
A 58-year-old male has 3 months of severely pruritic blistering skin lesions on his trunk, extremities, and groin. Lesions are large, tense, fluid-filled bullae on normal-appearing or slightly erythematous skin that do not rupture easily. He is systemically well. Skin biopsy shows subepidermal blister with eosinophilic infiltrate. Direct immunofluorescence (DIF) shows linear IgG and C3 at the basement membrane zone. Which of the following is the most likely diagnosis?
  • ADermatitis herpetiformis
  • BPemphigus vulgaris
  • CBullous pemphigoid
  • DStevens-Johnson syndrome
Reveal answer & full explanation
Correct answer: C — Bullous pemphigoid
  • ADermatitis herpetiformis
  • BPemphigus vulgaris
  • CBullous pemphigoid
  • DStevens-Johnson syndrome

Why Bullous pemphigoid is correct

  • Tense, large bullae on normal or erythematous skin that do not rupture easily in an elderly patient are classic for bullous pemphigoid (BP)
  • Subepidermal blister with eosinophilic infiltrate on biopsy plus linear IgG and C3 at the basement membrane zone (BMZ) on direct immunofluorescence are diagnostic
  • Autoantibodies target BP180 (collagen XVII) and BP230 in the hemidesmosome, causing complement activation, neutrophil/eosinophil recruitment, and a subepidermal blister at the dermal-epidermal junction
  • Tense bullae occur because the subepidermal cleavage plane leaves an intact epidermal roof that withstands turgidity
  • Nikolsky sign is NEGATIVE in BP

Why the others are wrong

  • Dermatitis herpetiformis — shows granular IgA (not linear IgG/C3) and is associated with celiac disease; presents with grouped pruritic vesicles on extensor surfaces (confused-with, wrong immunofluorescence pattern)
  • Pemphigus vulgaris — intraepidermal acantholytic bullae that are flaccid and rupture easily into erosions, with intercellular ("chicken-wire") IgG and a positive Nikolsky sign (confused-with, wrong cleavage plane)
  • Stevens-Johnson syndrome — acute, drug-triggered mucocutaneous erosions with epidermal necrosis; not chronic and lacks the linear BMZ DIF pattern described (right-concept-wrong-setting)

Additional high-yield points

  • Bullous pemphigoid is the most common autoimmune blistering disorder; typically affects patients over 70 and is associated with neurologic disease (dementia, Parkinson disease, stroke)
  • Treatment: topical high-potency corticosteroids (clobetasol propionate 0.05%) — the BLISTER trial showed equivalence to systemic steroids with fewer side effects
  • Widespread disease: systemic prednisone 0.5 mg/kg/day
  • Steroid-sparing options: doxycycline 100 mg BID plus niacinamide 1.5 g/day; azathioprine; mycophenolate; rituximab for refractory disease
Question 2DermatologyMedium
A 76-year-old woman is evaluated for a 6-week history of intractable itching followed by the appearance of large, tense fluid-filled blisters on her lower abdomen, inner thighs, and forearms. The blisters arise on urticarial plaques and remain intact when lateral pressure is applied. A lesional biopsy shows a subepidermal blister with an eosinophil-rich dermal infiltrate, and perilesional direct immunofluorescence reveals linear deposition of IgG and C3 along the basement membrane zone. To distinguish her condition from epidermolysis bullosa acquisita, salt-split skin direct immunofluorescence is performed. Which of the following findings best supports the suspected diagnosis?
  • AGranular IgA deposits within the dermal papillae tips
  • BIgG and C3 bind the dermal floor of the split skin
  • CIgG and C3 bind the epidermal roof of the split skin
  • DNetlike intraepidermal IgG between keratinocytes
Reveal answer & full explanation
Correct answer: C — IgG and C3 bind the epidermal roof of the split skin
  • AGranular IgA deposits within the dermal papillae tips
  • BIgG and C3 bind the dermal floor of the split skin
  • CIgG and C3 bind the epidermal roof of the split skin
  • DNetlike intraepidermal IgG between keratinocytes

Why IgG and C3 bind the epidermal roof of the split skin is correct

  • The clinical picture (elderly woman, prodromal pruritus, tense bullae on an urticarial base, subepidermal split with eosinophils, linear IgG/C3 at the basement membrane zone) is classic bullous pemphigoid.
  • Salt-split skin DIF cleaves the skin through the lamina lucida. In BP the target antigens BP180 (collagen XVII) and BP230 sit in the upper part of the basement membrane, so autoantibodies bind the epidermal (roof) side.
  • This is the single best discriminator from epidermolysis bullosa acquisita (EBA), whose antibodies target type VII collagen in the sublamina densa and therefore bind the dermal (floor) side.

Why the others are wrong

  • IgG and C3 binding the dermal floor of the split skin is the pattern of EBA (anti-type VII collagen); it is the exact entity the test is meant to exclude, so it argues against BP.
  • Granular IgA deposits within the dermal papillae tips are the hallmark of dermatitis herpetiformis, a celiac-associated disorder of young adults with grouped extensor vesicles, not subepidermal IgG/C3 disease in the elderly.
  • Netlike intraepidermal IgG between keratinocytes is the intercellular ("chicken-wire") pattern of anti-desmoglein pemphigus vulgaris, which produces flaccid bullae, painful oral erosions, a positive Nikolsky sign, and an intraepidermal split, all absent here.
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Bullous Pemphigoid outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Age >70
  • Neurodegenerative disease (Parkinson, Alzheimer dementia, stroke, MS)
  • Drugs: DPP-4 inhibitors (sitagliptin, linagliptin, vildagliptin), PD-1/PD-L1 inhibitors, furosemide, penicillins, sulfasalazine
  • Recent UV exposure or radiotherapy (can trigger localized disease)

Pathophysiology

IgG autoantibodies bind BP180 (collagen XVII) at the NC16A domain and BP230 within the hemidesmosomal plaque. Complement activation, mast cell degranulation, and eosinophil recruitment release proteases that cleave the lamina lucida, producing subepidermal separation with preservation of the overlying epidermis (hence tense, intact bullae).

Clinical presentation

Symptoms

  • Severe generalized pruritus, often weeks to months before blisters appear (prodromal or non-bullous phase)
  • Tense fluid-filled blisters arising on urticarial or normal-appearing skin
  • Predilection for flexural areas: lower abdomen, inner thighs, axillae, groin, forearms
  • Oral involvement in 10-30%, typically mild erosions without prominent pain

Signs / physical exam

  • Tense, intact bullae 1-3 cm on erythematous or urticarial plaques
  • Negative Nikolsky sign in classic disease
  • Excoriations and post-inflammatory hyperpigmentation
  • Mucosa usually spared; if involved, mild and non-scarring

Classic findings

Severe pruritus and tense bullae on an urticarial base in an elderly patient.

Differential diagnosis

  • Pemphigus vulgaris — Flaccid bullae, almost-universal painful oral erosions, positive Nikolsky, intraepidermal split, anti-desmoglein antibodies
  • Dermatitis herpetiformis — Intensely pruritic grouped vesicles on extensor surfaces in young adults; associated with celiac; granular IgA at dermal papillae
  • Epidermolysis bullosa acquisita — Blisters on trauma-prone sites, milia, scarring; antibodies to type VII collagen; salt-split skin binds dermal side
  • Linear IgA bullous dermatosis — "String of pearls" annular vesicles; vancomycin a common trigger; linear IgA at basement membrane on DIF
  • Bullous drug eruption / SJS/TEN — Acute onset after offending drug; targetoid lesions, mucosal involvement, full-thickness epidermal necrosis on biopsy
  • Bullous arthropod reaction — Localized clustered tense vesicles on exposed skin; preceding bite history; eosinophilic dermal infiltrate without antibody deposition

Diagnostic workup

Diagnostic criteria

Diagnosis requires clinical features plus histopathology and immunofluorescence. Lesional biopsy: subepidermal blister with eosinophil-rich dermal infiltrate. Perilesional DIF: linear deposition of IgG and C3 along the basement membrane zone. Salt-split skin DIF: antibodies bind the epidermal (roof) side, distinguishing BP from EBA.

Labs

  • Serum ELISA for anti-BP180 NC16A and anti-BP230 IgG (BP180 titers correlate with disease activity)
  • CBC: peripheral eosinophilia common
  • Pre-treatment hepatitis B/C, HIV, TB screen, glucose, lipids
  • Review medication list with emphasis on DPP-4 inhibitors and checkpoint inhibitors

Imaging

  • No routine imaging; tailor to comorbid evaluation
  • Consider age-appropriate malignancy screening if atypical presentation, but routine paraneoplastic workup is not indicated

Diagnostic algorithm

flowchart TD
  A[Elderly patient with<br/>itch ± tense bullae] --> B[Skin biopsy x2:<br/>lesional H&E +<br/>perilesional DIF]
  B --> C{DIF: linear<br/>IgG/C3 at BMZ?}
  C -->|Yes| D[Serum anti-BP180/BP230<br/>ELISA]
  C -->|No| E[Consider PV, DH,<br/>EBA, LABD]
  D --> F{Disease extent}
  F -->|Localized / mild| G[Clobetasol 0.05%<br/>whole-body topical<br/>± doxycycline + niacinamide]
  F -->|Moderate-severe| H[Prednisone 0.5 mg/kg<br/>+ steroid-sparing agent]
  H --> I{Refractory?}
  I -->|Yes| J[Rituximab,<br/>IVIG, omalizumab]
  I -->|No| K[Slow taper<br/>over months]
Bullous pemphigoid — diagnostic and treatment pathway.

Treatment

First-line

  • Localized or mild disease: superpotent topical corticosteroid — clobetasol propionate 0.05% applied to the entire body 30-40 g/day (per Joly NEJM 2002 trial showing equivalent efficacy to oral steroids with fewer adverse events)
  • Moderate-to-severe disease: prednisone 0.5 mg/kg/day with taper as disease controls; goal taper to <10 mg/day within months
  • Tetracycline-class antibiotic (doxycycline 200 mg/day) with or without nicotinamide — comparable efficacy to oral prednisone in mild-moderate disease (BLISTER trial, Williams Lancet 2017)
  • Wound care and itch management; sedating antihistamines (hydroxyzine, diphenhydramine) cautiously in elderly

Second-line / adjunct

  • Steroid-sparing immunosuppressants: methotrexate, azathioprine, mycophenolate mofetil
  • Rituximab for refractory or steroid-dependent disease
  • Omalizumab and dupilumab — emerging biologic options targeting IgE and IL-4/IL-13 pathways
  • Stop offending medication (DPP-4 inhibitor, checkpoint inhibitor where feasible)

Complications

  • Secondary bacterial infection, cellulitis, sepsis
  • Steroid morbidity in elderly: hyperglycemia, osteoporosis, fractures, delirium
  • Increased 1-year mortality (10-40% in elderly with comorbidities), often from infection or cardiovascular events rather than the disease itself
  • Recurrence after taper of therapy

PANCE pearls

  • Non-bullous prodromal phase can mimic chronic urticaria, scabies, or eczema for months before blisters appear; high index of suspicion in elderly patients with intractable itch.
  • Salt-split skin direct immunofluorescence distinguishes BP (epidermal/roof side) from epidermolysis bullosa acquisita (dermal/floor side).
  • Whole-body clobetasol is genuinely first-line for many elderly patients and avoids systemic steroid morbidity.
  • DPP-4 inhibitors — especially linagliptin and vildagliptin — are now a recognized iatrogenic trigger; switch class if BP develops.
  • Strong association with neurologic disease; ask about Parkinson disease, dementia, or stroke.

References

  • AAD/EADV 2022 — European S2k guidelines for the management of bullous pemphigoid (Borradori et al., JEADV 2022)
  • Joly NEJM 2002 — A comparison of oral and topical corticosteroids in patients with bullous pemphigoid (Joly et al., NEJM 2002)
  • BLISTER Trial — Doxycycline versus prednisolone as initial treatment for bullous pemphigoid (Williams et al., Lancet 2017)

Practice Dermatology questions on FirstPassPA

Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Answer the 2 free questions above → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.